ACCESSION: MSBNK-SMB_Measured-HSA001P0262002
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 15
COMMENT: RAW_SPEC {'16_posi_5342': {'bp': 149673.0, 'sum': 331366.0}, '16_posi_5408': {'bp': 102124.0, 'sum': 255452.0}, '14_posi_5341': {'bp': 93810.0, 'sum': 280257.0}, '12_posi_5345': {'bp': 57910.0, 'sum': 165425.0}, '18_posi_5361': {'bp': 54376.0, 'sum': 145831.0}, '15_posi_5384': {'bp': 54640.0, 'sum': 143313.0}, '9_posi_5364': {'bp': 82206.0, 'sum': 219258.0}, '5_posi_5321': {'bp': 76349.0, 'sum': 204417.0}, '17_posi_5367': {'bp': 123062.0, 'sum': 293489.0}, '19_posi_5409': {'bp': 111385.0, 'sum': 258140.0}, '6_posi_5345': {'bp': 75073.0, 'sum': 200159.0}, '13_posi_5343': {'bp': 67381.0, 'sum': 174890.0}, '13_posi_5280': {'bp': 41605.0, 'sum': 116464.0}, '12_posi_5277': {'bp': 32594.0, 'sum': 86119.0}, '9_posi_5279': {'bp': 54647.0, 'sum': 139106.0}}
COMMENT: RETENTION_TIME_STDEV 0.083
COMMENT: PRECURSOR_M/Z_RAW 262.164459
COMMENT: PRECURSOR_M/Z_STDEV 0.000082
COMMENT: PRECURSOR_IN_MS1 mz 262.164995; int 25.196; delta(ppm) 1.390736
COMMENT: PROPOSED_CHARGE_STATE +1; mz 263.168447; int 2.970; cor 0.855
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.364; C12H23NO5; [M+H]+; delta(ppm) 0.363765
COMMENT: PROPOSED_MF MS-FINDER 3.601; C12H23NO5; [M+H]+; delta(ppm) 0.361288
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.336; C12H23NO5; [M+H]+; delta(ppm) 0.361288
COMMENT: PROPOSED_MF SIRIUS5_Sirius 11.878; C13H19N5O; [M+H]+; delta(ppm) -4.740111
COMMENT: PROPOSED_MF SIRIUS5_Sirius 9.134; C15H20BFO2; [M+H]+; delta(ppm) 39710.112616
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C16H23NS; [M+H]+; delta(ppm) 9.905414
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.590; C12H23NO5; [M+H]+; delta(ppm) 0.361288
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.381; C13H19N5O; [M+H]+; delta(ppm) -4.740111
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.029; C15H20BFO2; [M+H]+; delta(ppm) 39710.112616
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.726; C12H23NO5; [M+H]+; delta(ppm) 0.361288
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.268; C13H19N5O; [M+H]+; delta(ppm) -4.740111
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.524; C15H20BFO2; [M+H]+; delta(ppm) 39710.112616
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.511; C10H21N4O4; [M+H]+; delta(ppm) 5.482763
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.078; C13H24FNOS; [M+H]+; delta(ppm) 5.546817
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.120; C13H27NS2; [M+H]+; delta(ppm) -2.953477
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.110; C10H20FN5O2; [M+H]+; delta(ppm) -9.098580
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.665; C11H17N8; [M+H]+; delta(ppm) 0.381312
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.696; C9H22N6OP; [M+H]+; delta(ppm) -5.919139
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.681; C7H20N9P; [M+H]+; delta(ppm) -0.797728
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.605; C12H23NO5; [M+H]+; delta(ppm) 0.361288
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.380; C13H19N5O; [M+H]+; delta(ppm) -4.740111
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.010; C15H20BFO2; [M+H]+; delta(ppm) 39710.112616
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.003; C13H24FNOS; [M+H]+; delta(ppm) 5.546817
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C10H21N4O4; [M+H]+; delta(ppm) 5.482763
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.059; BWAQHMTWORTVIR-ZPYYGDTRNA-N; [M+H]+; C[C@H](O)C[C@H](O)[C@@H]1CC[C@@H]2[C@H](O)[C@H](O)[C@@H](CO)N12
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; DHRNMNHPSWBJEN-UHFFFAOYNA-N; [M+H]+; CC(C)CC(=O)OC(O)(CC([O-])=O)C[N+](C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; SHDVOJJCEZGPBX-QVDQXJPCSA-N; [M+H]+; CCC(O)CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; XYLDAPHHFZKKHL-LUFOVDHBNA-N; [M+H]+; CCCC(O)C(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; AITZGXDKERIISX-RLLBSPEJNA-N; [M+H]+; C[C@H](O)CC[C@@H]1C[C@@H](O)[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)N12
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.530; AITZGXDKERIISX-RLLBSPEJNA-N; [M+H]+; UNPD128184
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.530; BWAQHMTWORTVIR-ZPYYGDTRNA-N; [M+H]+; UNPD113463
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.527; BFUHRGXPEKKLCB-WYVCTLLJNA-N; [M+H]+; UNPD171357
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.513; DSWZPLOBJBUJDG-UHFFFAOYSA-N; [M+H]+; N-({3,4-dihydroxy-1-[(2-methoxyethoxy)methyl]cyclopentyl}methyl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.442; ALEHQUVOXVDBJC-UHFFFAOYSA-N; [M+H]+; 3,6-dihydroxy-5-methyl-4-oxo-3-[(trimethylazaniumyl)methyl]heptanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.434; SHDVOJJCEZGPBX-QVDQXJPCSA-N; [M+H]+; O-(3-hydroxyvaleryl)-L-carnitine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.416; XYLDAPHHFZKKHL-LUFOVDHBNA-N; [M+H]+; 2-hydroxypentanoyl-L-carnitine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.408; DHRNMNHPSWBJEN-UHFFFAOYNA-N; [M+H]+; hydroxyisovaleroyl carnitine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.399; WIBRTSNRTOPKSU-UHFFFAOYSA-N; [M+H]+; CNP0447649
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.321; OTUSSJGEYNMECS-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-3-[hydroxy-(trimethylazaniumyl)methyl]-6-methyl-4-oxoheptanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; AITZGXDKERIISX-RLLBSPEJNA-N; [M+H]+; UNPD128184
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BFUHRGXPEKKLCB-WYVCTLLJNA-N; [M+H]+; UNPD171357
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BWAQHMTWORTVIR-ZPYYGDTRNA-N; [M+H]+; UNPD113463
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ALEHQUVOXVDBJC-UHFFFAOYSA-N; [M+H]+; 3,6-dihydroxy-5-methyl-4-oxo-3-[(trimethylazaniumyl)methyl]heptanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; DSWZPLOBJBUJDG-UHFFFAOYSA-N; [M+H]+; N-({3,4-dihydroxy-1-[(2-methoxyethoxy)methyl]cyclopentyl}methyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.722; WIBRTSNRTOPKSU-UHFFFAOYSA-N; [M+H]+; CNP0447649
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.716; SHDVOJJCEZGPBX-QVDQXJPCSA-N; [M+H]+; O-(3-hydroxyvaleryl)-L-carnitine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.716; XYLDAPHHFZKKHL-LUFOVDHBNA-N; [M+H]+; 2-hydroxypentanoyl-L-carnitine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; DHRNMNHPSWBJEN-UHFFFAOYNA-N; [M+H]+; hydroxyisovaleroyl carnitine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; OTUSSJGEYNMECS-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-3-[hydroxy-(trimethylazaniumyl)methyl]-6-methyl-4-oxoheptanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.007; UQTWSBWPFGVCAK-SECBINFHSA-N; [M+H]+; ethyl (3R)-3-hydroxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; BPYLRGKEIUPMRJ-QMMMGPOBSA-N; [M+H]+; (2S)-3-[(2-methylpropan-2-yl)oxy]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.140; DJZCWTDKDFJARG-IUCAKERBSA-N; [M+H]+; (2S,3S)-2-hydroxy-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; PZPXSBUQUCRLAG-UHFFFAOYSA-N; [M+H]+; 2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-propan-2-yloxybutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.815; UQTWSBWPFGVCAK; [M+H]+; (R)-N-Boc-5-Amino-3-hydroxy-pentanoic acid ethyl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.660; WIBRTSNRTOPKSU; [M+H]+; 6-[(2,4-dihydroxy-3,3-dimethylbutanoyl)amino]hexanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.707; IGLHHSKNBDXCEY; [M+H]+; 3-[(3-hydroxy-3-methylbutanoyl)oxy]-4-(trimethylammonio)butanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.297; SLXIFGSAJLELRG; [M+H]+; N-(cyclopentylideneamino)-6-morpholin-4-ylpyridazin-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -248.043; DIBDHOFCFXCFCB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.369; SHDVOJJCEZGPBX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -253.266; BPYLRGKEIUPMRJ; [M+H]+; boc-o-tert-butyl-l-serine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.648; BFUHRGXPEKKLCB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.398; DSWZPLOBJBUJDG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -264.713; XYLDAPHHFZKKHL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.205; AITZGXDKERIISX; [M+H]+; (1R,2R,3R,5R,7R,8R)-5-(3-hydroxybutyl)-3-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizine-1,2,7-triol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -271.641; IYLLOGWYTRFRSF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -272.894; DHRNMNHPSWBJEN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.133; DEZUSWBHWQDROZ; [M+H]+; N,4-Dicyclopropyl-6-(3-methoxy-1-azetidinyl)-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -283.105; FDMZYWCLSJXOCU; [M+H]+; 4,5-Dihydro-5-((4-(2-pyridinyl)-1-piperazinyl)methyl)-2-oxazolamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.625; BWAQHMTWORTVIR; [M+H]+; (1S,2R,3R,5R,8R)-5-(1,3-dihydroxybutyl)-3-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizine-1,2-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.390; DQRXZTGBHIYUGA; [M+H]+; Pinacidil pyridine N-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -349.853; RCZGLSKHVXNRSR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -350.367; JPZIKVJZVMFYJM; [M+H]+; (2R,3R,4S,5R,6R)-4-amino-2-hex-5-enoxy-6-(hydroxymethyl)oxane-3,5-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -364.787; KHPPSUJXZQEZQW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -395.946; ZWAPPZIVBZAGKZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.599; UQTWSBWPFGVCAK; [M+H]+; (R)-N-Boc-5-Amino-3-hydroxy-pentanoic acid ethyl
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.619; QMDDEXYHSGCIRS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -217.352; UQTWSBWPFGVCAK; [M+H]+; ethyl (3S)-3-hydroxy-5-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -220.731; IZBCFXDXJUOCNZ; [M+H]+; 6-(Cyclohexylmethoxy)-9-methyl-9h-purin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -226.463; ZRURYXJTRCKFJS; [M+H]+; 6-(2-cyclohexylethoxy)-7H-purin-1-ium-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -249.042; PZPXSBUQUCRLAG; [M+H]+; 2-{[(Tert-butoxy)carbonyl]amino}-4-(propan-2-yloxy)butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -249.908; XVBLXIVDDBKYDH; [M+H]+; 2-(3-Cyclopropyl-5-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -254.897; DJZCWTDKDFJARG; [M+H]+; (2RS,3S)-3-tert-butyloxycarbonylamino-2-hydroxy-5-methylhexanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -262.648; NPXBHBYLFJZCIQ; [M+H]+; 2-(2-Cyclopropyl-6-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -264.286; IYLLOGWYTRFRSF; [M+H]+; 2-(4-Cyclopropyl-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -266.388; SLXIFGSAJLELRG; [M+H]+; 6-(4-Morpholinyl)-3(2H)-pyridazinone cyclopentylidenehydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.082; QMDDEXYHSGCIRS; [M+H]+; nan
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C12H24N1O5; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 10.709
MS$FOCUSED_ION: PRECURSOR_M/Z 262.164994
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-0090000000-a6c893f18f311cfa5e94
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  216.1232352 179.1713 216.123091 1.8508 57.18 0.9107 15 f{C10H18N1O4}/0.93ppm,p-C2H6O1
  244.1180202 326.6198 244.117859 1.7983 64.40 1.0000 15 f{C11H18N1O5}/0.29ppm,p-C1H6
  262.1283777 999.0000 262.128206 1.1063 0.00 0.8964 15 ?
PK$NUM_PEAK: 3
PK$PEAK: m/z int. rel.int.
  216.123235 179.17 179
  244.118020 326.62 326
  262.128378 999.00 999
//
